Antiproinflammatory effects of iodixanol (OptiPrep)-based density gradient purification on human islet preparations

Cell Transplantation

Volumn 19, Issue 12, 2010, Pages 1537-1546

  Mita, A ^a,d   Ricordi, C ^a,b   Messinger, S ^a   Miki, A ^a   Misawa, R ^a,d   Barker, S ^a   Molano, R D ^a   Haertter, R ^a   Khan, A ^a   Miyagawa, S ^a   Pileggi, A ^a   Inverardi, L ^a   Alejandro, R ^a   Hering, B J ^c   Ichii, Hirohito ^a,b,e  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Florida   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokine; Ficoll; Islet; OptiPrep; Purification; Transplantation

Indexed keywords

ENDOTOXIN; FICOLL; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; IODIXANOL; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOMATION; CELL COMPOSITION; CELL ISOLATION; CELL STRESS; CELL SURVIVAL; CELL VIABILITY; CYTOKINE PRODUCTION; DENSITY GRADIENT PURIFICATION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTERMETHOD COMPARISON; MACROPHAGE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PURIFICATION; QUANTITATIVE ANALYSIS;

ADOLESCENT; ADULT; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL SEPARATION; CELL SURVIVAL; CELLS, CULTURED; CENTRIFUGATION, DENSITY GRADIENT; CHEMOKINES; CONTRAST MEDIA; CYTOKINES; FEMALE; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, NUDE; MIDDLE AGED; THROMBOPLASTIN; TRIIODOBENZOIC ACIDS;

EID: 79951820672     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X516600     Document Type: Article

References (49)

1. Abdelli, S.; Ansite, J.; Roduit, R.; Borsello, T.; Matsumoto, I.; Sawada, T.; Allaman-Pillet, N.; Henry, H.; Beckmann, J. S.; Hering, B. J.; Bonny, C. Intracellular stress signaling pathways activated during human islet preparation and following acute cytokine exposure. Diabetes 53(11):2815-2823; 2004.
2. Aikin, R.; Maysinger, D.; Rosenberg, L. Cross-talk between phosphatidylinositol 3-kinase/AKT and c-Jun NH2-terminal kinase mediates survival of isolated human islets. Endocrinology 145(10):4522-4531; 2004.
3. Alejandro, R.; Mintz, D. H.; Noel, J.; Latif, Z.; Koh, N.; Russell, E.; Miller, J. Islet cell transplantation in type I diabetes mellitus. Transplant. Proc. 19(1 Pt. 3):2359-2361; 1987.
4. Alejandro, R.; Strasser, S.; Zucker, P. F.; Mintz, D. H. Isolation of pancreatic islets from dogs. Semiautomated purification on albumin gradients. Transplantation 50(2):207-210; 1990.
5. Arnush, M.; Heitmeier, M. R.; Scarim, A. L.; Marino, M. H.; Manning, P. T.; Corbett, J. A. IL-1 produced and released endogenously within human islets inhibits beta cell function. J. Clin. Invest. 102(3):516-526; 1998.
6. Barbaro, B.; Salehi, P.; Wang, Y.; Qi, M.; Gangemi, A.; Kuechle, J.; Hansen, M. A.; Romagnoli, T.; Avila, J.; Benedetti, E.; Mage, R.; Oberholzer, J. Improved human pancreatic islet purification with the refined UIC-UB density gradient. Transplantation 84(9):1200-1203; 2007.
7. Berney, T.; Molano, R. D.; Cattan, P.; Pileggi, A.; Vizzardelli, C.; Oliver, R.; Ricordi, C.; Inverardi, L. Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation 71(1):125-132; 2001.
8. Bottino, R.; Balamurugan, A. N.; Tse, H.; Thirunavukkaasu, C.; Ge, X. H.; Profozich, J.; Milton, M.; Ziegenfuss, A.; Trucco, M.; Piganelli, J. D. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 53(10):2559-2568; 2004.
9. Bottino, R.; Fernandez, L. A.; Ricordi, C.; Lehmann, R.; Tsan, M. F.; Oliver, R.; Inverardi, L. Transplantation of allogeneic islets of Langerhans in the rat liver: Effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 47(3):316-323; 1998.
10. Brandhorst, H.; Brandhorst, D.; Brendel, M. D.; Hering, B. J.; Bretzel, R. G. Assessment of intracellular insulin content during all steps of human islet isolation procedure. Cell Transplant. 7(5):489-495; 1998.
11. Casey, J. J.; Lakey, J. R.; Ryan, E. A.; Paty, B. W.; Owen, R.; O'Kelly, K.; Nanji, S.; Rajotte, R. V.; Korbutt, G. S.; Bigam, D.; Kneteman, N. N.; Shapiro, A. M. Portal venous pressure changes after sequential clinical islet transplantation. Transplantation 74(7):913-915; 2002.
12. Chadwick, D. R.; Robertson, G. S.; Toomey, P.; Contractor, H.; Rose, S.; James, R. F.; Bell, P. R.; London, N. J. Pancreatic islet purification using bovine serum albumin: The importance of density gradient temperature and osmolality. Cell Transplant. 2(4):355-361; 1993.
13. Delaney, C. A.; Pavlovic, D.; Hoorens, A.; Pipeleers, D. G.; Eizirik, D. L. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 138(6):2610-2614; 1997.
14. Fornoni, A.; Pileggi, A.; Molano, R. D.; Sanabria, N. Y.; Tejada, T.; Gonzalez-Quintana, J.; Ichii, H.; Inverardi, L.; Ricordi, C.; Pastori, R. L. Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation. Diabetologia 51(2):298-308; 2008.
15. Friberg, A. S.; Stahle, M.; Brandhorst, H.; Korsgren, O.; Brandhorst, D. Human islet separation utilizing a closed automated purification system. Cell Transplant. 17(12):1305-1313; 2008.
16. Froud, T.; Ricordi, C.; Baidal, D. A.; Hafiz, M. M.; Ponte, G.; Cure, P.; Pileggi, A.; Poggioli, R.; Ichii, H.; Khan, A.; Ferreira, J. V.; Pugliese, A.; Esquenazi, V. V.; Kenyon, N. S.; Alejandro, R. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am. J. Transplant. 5(8):2037-2046; 2005.
17. Goto, M.; Eich, T. M.; Felldin, M.; Foss, A.; Kallen, R.; Salmela, K.; Tibell, A.; Tufveson, G.; Fujimori, K.; Engkvist, M.; Korsgren, O. Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation 78(9):1367-1375; 2004.
18. Hanley, S.; Liu, S.; Lipsett, M.; Castellarin, M.; Rosenberg, L.; Tchervenkov, J.; Paraskevas, S. Tumor necrosis factor-alpha production by human islets leads to postisolation cell death. Transplantation 82(6):813-818; 2006.
19. Hering, B. J.; Kandaswamy, R.; Ansite, J. D.; Eckman, P. M.; Nakano, M.; Sawada, T.; Matsumoto, I.; Ihm, S. H.; Zhang, H. J.; Parkey, J.; Hunter, D. W.; Sutherland, D. E. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293(7):830-835; 2005.
20. Hering, B. J.; Kandaswamy, R.; Harmon, J. V.; Ansite, J. D.; Clemmings, S. M.; Sakai, T.; Paraskevas, S.; Eckman, P. M.; Sageshima, J.; Nakano, M.; Sawada, T.; Matsumoto, I.; Zhang, H. J.; Sutherland, D. E.; Bluestone, J. A. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am. J. Transplant. 4(3):390-401; 2004.
21. Ichii, H.; Inverardi, L.; Pileggi, A.; Molano, R. D.; Cabrera, O.; Caicedo, A.; Messinger, S.; Kuroda, Y.; Berggren, P. O.; Ricordi, C. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am. J. Transplant. 5(7):1635-1645; 2005.
22. Ichii, H.; Miki, A.; Yamamoto, T.; Molano, R. D.; Barker, S.; Mita, A.; Rodriguez-Diaz, R.; Klein, D.; Pastori, R.; Alejandro, R.; Inverardi, L.; Pileggi, A.; Ricordi, C. Characterization of pancreatic ductal cells in human islet preparations. Lab. Invest. 88(11):1167-1177; 2008.
23. Ichii, H.; Sakuma, Y.; Pileggi, A.; Fraker, C.; Alvarez, A.; Montelongo, J.; Szust, J.; Khan, A.; Inverardi, L.; Naziruddin, B.; Levy, M. F.; Klintmalm, G. B.; Goss, J. A.; Alejandro, R.; Ricordi, C. Shipment of human islets for transplantation. Am. J. Transplant. 7(4):1010-1020; 2007.
24. Ichii, H.; Wang, X.; Messinger, S.; Alvarez, A.; Fraker, C.; Khan, A.; Kuroda, Y.; Inverardi, L.; Goss, J. A.; Alejandro, R.; Ricordi, C. Improved human islet isolation using nicotinamide. Am. J. Transplant. 6(9):2060-2068; 2006.
25. Jahr, H.; Pfeiffer, G.; Hering, B. J.; Federlin, K.; Bretzel, R. G. Endotoxin-mediated activation of cytokine production in human PBMCs by collagenase and Ficoll. J. Mol. Med. 77(1):118-120; 1999.
26. Kin, T.; Senior, P.; O'Gorman, D.; Richer, B.; Salam, A.; Shapiro, A. M. J. Risk factors for islet loss during culture prior to transplantation. Transplant. Int. 21(11):1029-1035; 2008.
27. Lau, J.; Kampf, C.; Mattsson, G.; Nyqvist, D.; Kohler, M.; Berggren, P. O.; Carlsson, P. O. Beneficial role of pancreatic microenvironment for angiogenesis in transplanted pancreatic islets. Cell Transplant. 18(1):23-30; 2009.
28. Lee, I.; Wang, L.; Wells, A. D.; Ye, Q.; Han, R.; Dorf, M. E.; Kuziel, W. A.; Rollins, B. J.; Chen, L.; Hancock, W. W. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. J. Immunol. 171(12):6929-6935; 2003.
29. Markmann, J. F.; Deng, S.; Huang, X.; Desai, N. M.; Velidedeoglu, E. H.; Lui, C.; Frank, A.; Markmann, E.; Palanjian, M.; Brayman, K.; Wolf, B.; Bell, E.; Vitamaniuk, M.; Doliba, N.; Matschinsky, F.; Barker, C. F.; Naji, A. Insulin independence following isolated islet transplantation and single islet infusions. Ann. Surg. 237(6):741-750; 2003.
30. Matsumoto, S.; Okitsu, T.; Iwanaga, Y.; Noguchi, H.; Nagata, H.; Yonekawa, Y.; Yamada, Y.; Fukuda, K.; Shibata, T.; Kasai, Y.; Maekawa, T.; Wada, H.; Nakamura, T.; Tanaka, K. Successful islet transplantation from nonheartbeating donor pancreata using modified Ricordi islet isolation method. Transplantation 82(4):460-465; 2006.
31. Miki, A.; Ricordi, C.; Messinger, S.; Yamamoto, T.; Mita, A.; Barker, S.; Haetter, R.; Khan, A.; Alejandro, R.; Ichii, H. Toward improving human islet isolation from younger donors: Rescue purification is efficient for trapped islets. Cell Transplant. 18(1):13-22; 2009.
32. Mita, A.; Ricordi, C.; Miki, A.; Barker, S.; Haertter, R.; Hashikura, Y.; Miyagawa, S.; Burke, 3rd, G. W.; Inverardi, L.; Ichii, H. Anti-proinflammatory effects of sirolimus on human islet preparations. Transplantation 86(1):46-53; 2008.
33. Mita, A.; Ricordi, C.; Miki, A.; Barker, S.; Khan, A.; Alvarez, A.; Hashikura, Y.; Miyagawa, S.; Ichii, H. Purification method using iodixanol (OptiPrep)-based density gradient significantly reduces cytokine chemokine production from human islet preparations, leading to prolonged beta-cell survival during pretransplantation culture. Transplant. Proc. 41(1):314-315; 2009.
34. Movahedi, B.; Gysemans, C.; Jacobs-Tulleneers-Thevissen, D.; Mathieu, C.; Pipeleers, D. Pancreatic duct cells in human islet cell preparations are a source of angiogenic cytokines interleukin-8 and vascular endothelial growth factor. Diabetes 57(8):2128-2136; 2008.
35. Nano, R.; Clissi, B.; Melzi, R.; Calori, G.; Maffi, P.; Antonioli, B.; Marzorati, S.; Aldrighetti, L.; Freschi, M.; Grochowiecki, T.; Socci, C.; Secchi, A.; Di Carlo, V.; Bonifacio, E.; Bertuzzi, F. Islet isolation for allotransplantation: variables associated with successful islet yield and graft function. Diabetologia 48(5):906-912; 2005.
36. Noguchi, H.; Matsumoto, S.; Onaca, N.; Naziruddin, B.; Jackson, A.; Ikemoto, T.; Shimoda, M.; Fujita, Y.; Chujo, D.; Iwanaga, Y.; Nagata, H.; Okitsu, T.; Kobayashi, N.; Ueno, H.; Chaussabel, D.; Grayburn, P.; Banchereau, J.; Levy, M. F. Ductal injection of JNK inhibitors before pancreas preservation prevents islet apoptosis and improves islet graft function. Hum. Gene Ther. 20(1):73-85; 2009.
37. Piemonti, L.; Leone, B. E.; Nano, R.; Saccani, A.; Monti, P.; Maffi, P.; Bianchi, G.; Sica, A.; Peri, G.; Melzi, R.; Aldrighetti, L.; Secchi, A.; Di Carlo, V.; Allavena, P.; Bertuzzi, F. Human pancreatic islets produce and secrete MCP-1/CCL2: Relevance in human islet transplantation. Diabetes 51(1):55-65; 2002.
38. Ricordi, C.; Gray, D. W.; Hering, B. J.; Kaufman, D. B.; Warnock, G. L.; Kneteman, N. M.; Lake, S. P.; London, N. J.; Socci, C.; Alejandro, R.; Zeng, Y.; Scharp, D. W.; Viviani, G.; Falqui, L.; Tzakis, A.; Bretzel, R. G.; Federlin, K.; Pozza, G.; James, R. F. L.; Rajotte, R. V.; Di Carlo, V.; Morris, P. J.; Sutherland, D. E. R.; Starzl, T. E.; Mintz, D. H.; Lacy, P. E. Islet isolation assessment in man and large animals. Acta Diabetol. Lat. 27(3):185-195; 1990.
39. Ricordi, C.; Lacy, P. E.; Finke, E. H.; Olack, B. J.; Scharp, D. W. Automated method for isolation of human pancreatic islets. Diabetes 37(4):413-420; 1988.
40. Rodriguez-Mulero, S.; Montanya, E. Islet graft response to transplantation injury includes upregulation of protective as well as apoptotic genes. Cell Transplant. 17(9): 1025-1034; 2008.
41. Ryan, E. A.; Paty, B. W.; Senior, P. A.; Bigam, D.; Alfadhli, E.; Kneteman, N. M.; Lakey, J. R.; Shapiro, A. M. Five-year follow-up after clinical islet transplantation. Diabetes 54(7):2060-2069; 2005.
42. Sabek, O. M.; Cowan, P.; Fraga, D. W.; Gaber, A. O. The effect of isolation methods and the use of different enzymes on islet yield and in vivo function. Cell Transplant. 17(7):785-792; 2008.
43. Salvalaggio, P. R.; Deng, S.; Ariyan, C. E.; Millet, I.; Zawalich, W. S.; Basadonna, G. P.; Rothstein, D. M. Islet filtration: A simple and rapid new purification procedure that avoids ficoll and improves islet mass and function. Transplantation 74(6):877-879; 2002.
44. Scharp, D. W.; Kemp, C. B.; Knight, M. J.; Ballinge, W. F.; Lacy, P. E. Use of Ficoll in preparation of viable islets of Langerhans from rat pancreas. Transplantation 16(6):686-689; 1973.
45. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343(4):230-238; 2000.
46. Shapiro, J.; Lakey, J.; Paty, B.; Senior, P.; McDonald, C.; McCready, T.; Oberholzer, J.; Kneteman, N.; Rajotte, R.; Bigam, D.; O'Kelly, K.; Ryan, E. Clinical-islet transplantation in Edmonton - 3-year outcomes and new developments. Diabetes 52:A66; 2003.
47. Tran, P. O.; Gleason, C. E.; Robertson, R. P. Inhibition of interleukin-1beta-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet beta-cell function. Diabetes 51(6):1772-1778; 2002.
48. Urban, J. L.; Rothstein, J. L.; Shephard, M. H.; Schreiber, H. Tumor necrosis factor: A potent mediator of macrophage-dependent tumor-cell killing. Haematol. Blood Transfus. 31:351-354; 1987.
49. Warnock, G. L.; Ellis, D.; Rajotte, R. V.; Dawidson, I.; Baekkeskov, S.; Egebjerg, J. Studies of the isolation and viability of human islets of Langerhans. Transplantation 45(5):957-963; 1988.